Search

You searched for "Optics"

1866 results found

Ridley Eye Foundation’s Spring camp programme

2 August 2024 | | EYE - General
The Ridley Eye Foundation continues its work in taking surgery to patients in remote communities living above 2000m in Nepal’s Himalayas. This spring, between 28 March – 7 April 2024, we supported surgical camps in Jumla and Mugu, both in...

Pegcetacoplan: A breakthrough treatment for dry age-related macular degeneration?

12 February 2025 | | EYE - Pathology, EYE - Vitreo-Retinal
Age-related macular degeneration (AMD) is a degenerative condition affecting the macula, the part of the retina responsible for central vision. It is characterised by the presence of drusen and retinal pigment epithelium (RPE) abnormalities in the absence of other macular...

“My cataracts have been dissolved by eye drops!”

1 April 2018 | EYE - Cataract, EYE - Refractive
Simerdip Kaur takes a look at the latest ophthalmology-related news stories and asks which are scientific reality and which are ‘fake news’. Headline: “My cataracts have been dissolved by eye drops!” I’m sure some of us have had patients enquire...

Does a gut-eye axis exist?

1 October 2019 | | EYE - General
Simerdip Kaur takes a look at the latest ophthalmology-related news stories and asks which are based on facts and which are ‘fake news’. Headline: Does a gut-eye axis exist? Over a decade ago, the Human Microbiome Project was launched by...

Bovine pericardium scleral patch graft associated scleritis: Ahmed valve implant for pupillary block glaucoma

1 April 2016 | | EYE - Glaucoma, EYE - General
Processed bovine pericardium is a lyophilised collagen sheet used as a surgical armamentarium. It renders the material antigenically inert with minimal inflammation [1]. Sclera patch pericardium graft (Tutopatch) is a collagenous membrane derived from solvent preserved, irradiated bovine pericardium [2]...

A case of ‘60-day glaucoma’

3 April 2023 | | EYE - General
Neovascular glaucoma (NVG) has been called ‘90-’ or ‘100-day glaucoma’ in the past due to its typical development three months after the onset of central retinal vein occlusion (CRVO). In reality, NVG can occur anywhere between two weeks and two...

How to maximise points for your ophthalmology portfolio as a medical student

4 December 2023 | | EYE - General
Ophthalmology is an extremely popular and competitive career option, with one of the highest competition ratios at ST1 level entry (10:1 in 2023) [1]. It is also a highly rewarding speciality, involving: a mixture of medicine and surgery in a...

Thinking outside the box – adapting to the COVID-19 lockdown

5 August 2020 | | EYE - Glaucoma, EYE - General
How can we avoid further delays to follow-up in glaucoma patients? The author asks if there is a socially distanced way to check IOPs in those at high risk of losing vision. Glaucoma is an asymptomatic condition. Loss of the...

My top five: Innovative approaches to dry AMD

2 February 2024 | | EYE - Vitreo-Retinal
Age-related macular degeneration (AMD) is one of the leading causes of irreversible blindness in the developing world with its prevalence rising alongside age. In societies characterised by ageing populations, it is imperative we explore more effective treatment to alleviate the...

My Top Five: Promising gene therapies for ocular conditions

4 December 2024 | | EYE - Vitreo-Retinal
Gene therapy, a pivotal advancement in modern medicine, particularly shines in ophthalmology. By targeting defective genes with engineered vectors, this approach promises significant strides in treating inherited retinal diseases. This article reviews the top five gene therapies in late-stage trials,...

What’s Eating Gilbert Pete

2 August 2022 | | EYE - General
“Please phone Mr C Lyon ASAP on 0131 334 9171” This was a message from my secretary waiting for me on my computer one morning shortly after I was appointed a consultant. The name did not ring any bells but...

My Top Five: Innovative approaches to dry AMD

2 February 2024 | | EYE - General
Age-related macular degeneration (AMD) is one of the leading causes of irreversible blindness in the developing world with its prevalence rising alongside age. In societies characterised by ageing populations, it is imperative we explore more effective treatment to alleviate the...